Solid lipid nanoparticles as drug delivery system

International Journal of Pharma and Bio Sciences

Volumn 1, Issue 3, 2010, Pages

  kamble, Vishvajit A ^a   Jagdale, Deepali M ^a   kadam, Vilasrao J ^a  

^a BHARATI VIDYAPEETH S COLLEGE OF PHARMACY   (India)

Author keywords

Colloidal drug carriers; Nanocarrier; Nanotechnology; Solid lipid nanoparticles

Indexed keywords

DOXORUBICIN; DRUG CARRIER; FLURBIPROFEN; ISOTRETINOIN; LIPID EMULSION; MITOXANTRONE; SOLID LIPID NANOPARTICLE; SUNSCREEN; TAMOXIFEN; TUBERCULOSTATIC AGENT;

AGRICULTURAL PROCEDURES; ANTIBODY LABELING; ARTICLE; ATOMIC FORCE MICROSCOPY; CANCER CHEMOTHERAPY; COLORIMETRY; COSMETIC INDUSTRY; DIFFERENTIAL SCANNING CALORIMETRY; DOSE RESPONSE; DRUG ADMINISTRATION ROUTE; DRUG DELIVERY SYSTEM; DRUG DOSE REDUCTION; DRUG RELEASE; GENE VECTOR; HUMAN; INTERMETHOD COMPARISON; LIGHT SCATTERING; NANOPHARMACEUTICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PARTICLE SIZE; PATIENT COMPLIANCE; PHOTON CORRELATION SPECTROSCOPY; SCANNING ELECTRON MICROSCOPY; X RAY DIFFRACTION; ZETA POTENTIAL;

EID: 84455207541     PISSN: None     EISSN: 09756299     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Scheffel U, Rhodes BA, Natajaran TK, Wagner HN, 1970 Albumin microspheres for study of the reticulo endothelial system. J Nucl Med 13:498-503.
2. Jumaa M, Muller BW. 2000 Lipid emulsions as a novel system to reduce the hemolytic activity of lytic agents: Mechanism of protective effect. Eur J Pharm Sci 9:285-90.
3. Cavalli R, Caputo O, Gasco MR. 1993 Solid lipospheres of doxorubicin and idarubicin. Int J Pharm 89:R9-R12.
4. Gasco MR. Method for producing solid lipid microspheres having a narrow size distribution. United states patent, US 188837; 1993.
5. Speiser P. Lipidnanopellets als Tragersystem fur Arzneimittel zur perolen Anwendung. European Patent, EP 0167825; 1990.
6. Domb AJ. Lipospheres for controlled delivery of substances. United States Patent, US 188837; 1993
7. Ahlin P, Kristl J, Kobar S. Optimization of procedure parameters and physical stability of solid lipid nanoparticles in dispersion. Acta Pharm1998; 48: 257-67.
8. Olbrich C, Gebner A, Kayser O, Muller RH. Lipid-drug conjugate (LDC) nanoparticles as novel carrier system for the hydrophilic antitrypanosomal drug diminazenediaceturate. J Drug Target 2002; 10:387-96.
9. Lander R, Manger W, Scouloudis M, Ku A, Davis C, Lee A. Gaulin homogenization: a mechanistic study. Biotechnol Prog 2000; 16:80-5.
10. Jahnke S.The theory of high pressure homogenization. In: Muller RH, Benita S, Bohm B. editors. Emulsions and nanosuspensions for the formulation of poorly soluble drugs Stuttgart: Medpharm Scientific Publishers; 1998. p. 177-200.
11. Mullenzur A, Feste Lipid-Nanopartikel mit prolongierter Wirkstoffliberation: Herstellung, Langzeitstabilitat, Charakterisierung, Freisetzungsverhalten und mechanismen. Ph.D. Thesis, Free University of Berlin, 1996.
12. Eldem T, Speiser P, Hincal A. Optimization of spray-dried and congealed lipid microparticles and characterization of their surface morphology by scanning electron microscopy. Pharm Res 1991; 8:47-54
13. Speiser P. Lipidnanopellets als Tragersystem fur Arzneimittel zur peroralem Anwendung. European Patent No. EP 0167825; 1990.
14. Gasco MR. Method for producing solid lipid microspheres having narrow size distribution. United State Patent. US 188837; 1993.
15. Gasco MR. Solid lipid nanospheres from warm microemulsions. Pharm Tech Eur 1997; 9:52-8.
16. Boltri L, Canal T, Esposito PA, Carli F. Lipid nanoparticles: Evaluation of some critical formulation parameters. Proc Intern Symp Control Rel Bioact Mater 1993; 20:346-7.
17. De Labouret A, Thioune O, Fessi H, Devissaguet JP, Puiseieux F. Application of an original process for obtaining colloidal dispersions of some coating polymers: Preparation, Charecterization, industrial scaling up. Drug Develop Ind Pharm 1995; 21:229-41.
18. Cavalli R, Marengo E, Rodriguez L, Gasco MR. Effects of some experimental factors on the production process of solid lipid nanoparticles. Eur J Pharm Biopharm 1996; 43: 110-5.
19. Chen YJ, Jin RX, Zhou YQ, Zeng J, Zhang H, Feng QR. Preparation of solid lipid nanoparticles loaded with Xionggui powdersupercritical carbon dioxide fluid extraction and their evaluation in vitro release. Zhongguo Zhong Yao Za Zhi 2006; 31:376-9.
20. Kaiser CS, Rompp H, Schmidt PC. Pharmaceutical applications of supercritical carbon dioxide. Pharmazie 2001;56: 907-26.
21. Gosselin PM, Thibert R, Preda M, McMullen JN. Polymeric properties of micronized carbamazepine produced by RESS. Int J Pharm 2003; 252:225-33.
22. Sjostrom B, Bergenstahl B. Preparation of submicron drug particles in lecithin-stabilized o/w emulsions: I: Model studies of the precipitation of cholesteryl acetate. Int J Pharm 1992; 88: 53-62.
23. Siekmann B, Westesen K. Investigations on solid lipid nanoparticles prepared by precipitation in o/w emulsions. Eur J Pharm Biopharm 1996; 43: 104-9.
24. Cortesi R, Esposito E, Luca G, Nastruzzi C. Production of lipospheres as carriers for bioactive compounds. Biomaterials 2002; 23:2283-94.
25. Freitas C, Muller RH. Spray-drying of Solid lipid nanoparticles (SLN TM). Eur J Pharm Biopharm 1998; 46: 145-51.
26. Yang S, Zhu J, Lu Y, Ling B, Yang C. Body distribution of camptothecin solid lipid nanoparticles after oral administration. Pharm Res 1999; 16: 751-7.
27. Yang SC, Lu LF, Cai Y, Zhu JB, Liang BW, Yang CZ. Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. J Control Release 1999;59:299-307.
28. Prow T, Smith JN, Grebe R, Salazar JH, Wang N, Kotov N, et al. Construction, gene delivery, and expression of DNA tethered nanoparticles. Mol Vis 2006; 12:606-15.
29. Meyer E, Heinzelmann H. Scanning force microscopy. In: Wiesendanger R, Guntherodt HJ, editors. Scanning tunneling microscopy II, Surface science. New York: Springer Verlag; 1992. p. 99-149.
30. Drake B, Prater CB, Weisenhorn AL, Gould SAC, Albrecht TR, Quate CF, et al. Imaging crystals polymers and process in water with the AFM. Science 1989; 243:1586-9.
31. Muller RH, Runge SA. Solid lipid nanoparticles (SLN) for controlled drug delivery. In: Benita S, editor. Submicron emulsions in drug targeting and delivery, Amsterdam: Harwood Academic Publishers; 1998. p. 219-34.
32. Jenning V, Gysler A, Schafer-Korting M, Gohla S. Vitamin A loaded solid lipid nanoparticles for topical use Eur J Pharm Biopharm 2000;49:211-8.
33. Muller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 2002;54: S131-55.
34. Pandey R, Sharma S, Khuller GK. Oral SLN Based antitubercular chemotherapy. Tuberculosis (Edinb) 2005;85: 415-20.
35. Chen H, Chang X, Du D, Liu W, Liu J, Weng T, et al. Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J Control Release 2006;110: 296-306.
36. Jenning V, Schafer-Korting M, Gohla S. Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties. J Control Release 2000;66: 115-26.
37. Santos MC, Mehnert W, Schaller M. Drug targeting by solid lipid nanoparticles for dermal use. J Drug Target 2002;10:489-95.
38. Wissing SA, Muller RH. Solid lipid nanoparticles (SLN) a novel carrier for UV blockers. Pharmazie 2001;56:783-6.
39. Rudolph C, Schillinger U, Ortiz A, Tabatt K, Plank C, Muller RH, et al. Application of novel Solid lipid nanoparticles (SLN)- gene vector formulations based on a diametric HIV-1 VAT - peptide in vitro and in vivo. Pharmaceutic Res 2004;21:1662-9.
40. Hayes ME, Drummond DC, Kirpotin DB. Selfassembling nucleic acid-lipid nanoparticles suitable for targeted gene delivery. Gene Ther 2006;13:646-51.
41. Lu B, Xiong SB, Yang H., Yin XD, Chao RB. Solid lipid nanoparticles of mitoxantrone for local injection against breast cancer and its lymphnode metastases. Eur J Pharm Sci 2006; 28:86-95.
42. Shenoy VS, Vijay IK, Murthy RS. Tumour targeting: Biological factors and formulation advances in injectable lipid nanoparticles. J Pharm Pharmacol 2005; 57:411-22.
43. Ruckmani K, Sivakumar M, Ganeshkumar PA. Methotrexate loaded solid lipid nanoparticles (SLN) for effective treatment of carcinoma. J Nanosci Nanotechnol 2006; 6:2991-5.
44. Yang SC, Lu LF, Cai Y, Zhu JB, Liang BW, Yang CZ. Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. J Control Release 1999; 59:299-307.
45. Wang Y, Wu W. In situ evading of phagocytic uptake of stealth solid lipid nanoparticles by mouse peritoneal macrophages. Drug Deliv 2006; 13:189-92.
46. Lai F, Wissing SA, Muller RH, Fadda AM. Artemisia arborescens L essential oil-loaded solid lipid nanoparticles for potential agriculture application: Preparation and characterization. AAPS Pharm Sci Tech 2006; 7:E2.